Showing results (411-420 of 2,330) with videos related to
Sort By:
Pageof 233
Clinical Drug Investigation|March 16, 2020
Revisiting Therapies for Atopic Dermatitis that Failed Clinical TrialsGaurav Agnihotri, Peter A LioClinical Drug Investigation|December 5, 2019
PCSK9 Inhibitors' New Users: Analysis of Prescription Patterns and Patients' Characteristics from an Italian Real-world StudyCarlo Piccinni, Ippazio Cosimo Antonazzo, Aldo P Maggioni, et al.Clinical Drug Investigation|September 23, 2020
Treatment and Healthcare Cost Among Patients with Hip or Knee Osteoarthritis: A Cross-sectional Study Using a Real-world Claims Database in Japan Between 2013 and 2019Nozomi Ebata-Kogure, Aya Murakami, Kazutaka Nozawa, et al.Clinical Drug Investigation|December 17, 2020
Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral AntipsychoticsJörg Mahlich, Kerstin Olbrich, Adrian Wilk, et al.Clinical Drug Investigation|December 20, 2020
Targeted Use of Prednisolone with Intravenous Immunoglobulin for Kawasaki DiseaseHidemasa Sakai, Satoru Iwashima, Shinichiro Sano, et al.Clinical Drug Investigation|October 18, 2020
Treatment of Major Depressive Disorder in Japanese Patients with Cancer: A Matched Cohort Study Using Employer-Based Health Insurance Claims DataTatsuo Akechi, Shinji Fujimoto, Izumi Mishiro, et al.Clinical Drug Investigation|March 16, 2021
Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its UseSheridan M HoyClinical Drug Investigation|March 6, 2021
Cost-effectiveness Analysis of Atezolizumab Plus Nab-Paclitaxel for Advanced PD-L1 Positive Triple-Negative Breast Cancer in JapanYugo Chisaki, Yoshiki Kuwada, Chikako Matsumura, et al.Clinical Drug Investigation|March 7, 2021
Safety and Efficacy of Rivaroxaban and Apixaban in Patients with Increased Body Mass: a Systematic ReviewMargaret M Buck, Alexa M Haddon, Antonietta Paneccasio, et al.Pageof 233